Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Current-Liabilities" stands at 16.80 Billion United States Dollars as of 09/30/2025.
As of the end of Amgen Inc's third quarter, the item "Other Current Liabilities" stands at 16.80 Billion USD. This represents an increase of 11.84 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.90 percent compared to the value the year prior.
The 1 year change in percent is 14.90.
The 3 year change in percent is 45.03.
The 5 year change in percent is 93.08.
The 10 year change in percent is 246.53.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Current Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Current Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Current Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Current Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Current Liabilities | 280,205,508,085.11 |